Rapt Therapeutics Inc
(RAPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 19,371 | 19,535 | 19,265 | 54,465 | 19,788 |
| Operating Income | -19,371 | -19,535 | -19,265 | -54,465 | -19,788 |
| Other Income | 1,791 | 1,892 | 2,100 | 1,216 | 1,356 |
| Pre-tax Income | -17,580 | -17,643 | -17,165 | -53,249 | -18,432 |
| Net Income Continuous | -17,580 | -17,643 | -17,165 | -53,249 | -18,432 |
| Net Income | $-17,580 | $-17,643 | $-17,165 | $-53,249 | $-18,432 |
| EPS Basic Total Ops | -0.65 | -0.65 | -0.64 | -9.72 | -3.79 |
| EPS Basic Continuous Ops | -0.65 | -0.65 | -0.64 | -9.68 | -3.79 |
| EPS Diluted Total Ops | -0.65 | -0.65 | -0.64 | -9.72 | -3.79 |
| EPS Diluted Continuous Ops | -0.65 | -0.65 | -0.64 | -9.68 | -3.79 |
| EPS Diluted Before Non-Recurring Items | -0.65 | -0.65 | -0.64 | -9.12 | -3.76 |
| EBITDA(a) | $-19,901 | $-20,147 | $-19,706 | $-54,708 | $-20,043 |